Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women.

Massad LS, Evans CT, Minkoff H, Watts DH, Greenblatt RM, Levine AM, Anastos K, Young M, Seifer DB, Golub E, Cohen M.

J Womens Health (Larchmt). 2006 Jun;15(5):591-8.

PMID:
16796486
[PubMed - indexed for MEDLINE]
2.

Effect of HIV-1 infection and increasing immunosuppression on menstrual function.

Ezechi OC, Jogo A, Gab-Okafor C, Onwujekwe DI, Ezeobi PM, Gbajabiamila T, Adu RA, Audu RA, Musa AZ, Salu OB, Meschack E, Herbertson E, Odunukwe N, Idigbe OE.

J Obstet Gynaecol Res. 2010 Oct;36(5):1053-8.

PMID:
21058440
[PubMed - indexed for MEDLINE]
3.

Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).

Anastos K, Kalish LA, Palacio H, Benson CA, Delapenha R, Chirgwin K, Stonis L, Telzak EE.

J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):141-7.

PMID:
10360806
[PubMed - indexed for MEDLINE]
4.

Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).

Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J, Holmberg S, Graham NM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):253-61.

PMID:
9495226
[PubMed - indexed for MEDLINE]
5.

Contraceptive use among U.S. women with HIV.

Massad LS, Evans CT, Wilson TE, Golub ET, Sanchez-Keeland L, Minkoff H, Weber K, Watts DH.

J Womens Health (Larchmt). 2007 Jun;16(5):657-66.

PMID:
17627401
[PubMed - indexed for MEDLINE]
6.

Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome.

Chirgwin KD, Feldman J, Muneyyirci-Delale O, Landesman S, Minkoff H.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):489-94.

PMID:
8757426
[PubMed - indexed for MEDLINE]
7.

Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV.

Massad LS, Springer G, Jacobson L, Watts H, Anastos K, Korn A, Cejtin H, Stek A, Young M, Schmidt J, Minkoff H.

AIDS. 2004 Jan 23;18(2):281-6.

PMID:
15075546
[PubMed - indexed for MEDLINE]
8.

A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.

Navazesh M, Mulligan R, Barrón Y, Redford M, Greenspan D, Alves M, Phelan J; Women's Interagency HIV Study participants.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jun;95(6):693-8.

PMID:
12789150
[PubMed - indexed for MEDLINE]
9.

Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.

Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ.

Clin Infect Dis. 2004 Sep 1;39(5):717-24. Epub 2004 Aug 16.

PMID:
15356788
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.

Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA.

Clin Infect Dis. 2004 Feb 15;38(4):579-84. Epub 2004 Jan 30.

PMID:
14765353
[PubMed - indexed for MEDLINE]
Free Article
11.

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G; Italian MASTER Cohort.

Antivir Ther. 2007;12(6):941-7.

PMID:
17926648
[PubMed - indexed for MEDLINE]
12.

Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.

Klein RS, Sobel J, Flanigan T, Smith D, Margolick JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):238-44.

PMID:
10077171
[PubMed - indexed for MEDLINE]
13.

Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus.

Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, Heather Watts D.

Am J Obstet Gynecol. 2004 May;190(5):1241-8. Erratum in: Am J Obstet Gynecol. 2004 Nov;191(5):1842-4.

PMID:
15167825
[PubMed - indexed for MEDLINE]
14.

Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV.

Massad LS, Fazzari MJ, Anastos K, Klein RS, Minkoff H, Jamieson DJ, Duerr A, Celentano D, Gange S, Cu-Uvin S, Young M, Watts DH, Levine AM, Schuman P, Harris TG, Strickler HD.

J Low Genit Tract Dis. 2007 Apr;11(2):90-7.

PMID:
17415113
[PubMed - indexed for MEDLINE]
15.

Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.

Floris-Moore M, Howard AA, Lo Y, Arnsten JH, Santoro N, Schoenbaum EE.

HIV Med. 2006 Oct;7(7):421-30.

PMID:
16925727
[PubMed - indexed for MEDLINE]
16.

Risk factors for genital ulcerations in Kenyan sex workers. The role of human immunodeficiency virus type 1 infection.

Kaul R, Kimani J, Nagelkerke NJ, Plummer FA, Bwayo JJ, Brunham RC, Ngugi EN, Ronald A.

Sex Transm Dis. 1997 Aug;24(7):387-92.

PMID:
9263358
[PubMed - indexed for MEDLINE]
17.

Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team.

Cu-Uvin S, Wright DJ, Anderson D, Kovacs A, Watts DH, Cohn J, Landay A, Reichelderfer PS.

J Womens Health Gend Based Med. 2000 Oct;9(8):857-63.

PMID:
11074951
[PubMed - indexed for MEDLINE]
18.

Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.

Sirera G, Videla S, López-Blázquez R, Llatjos M, Tarrats A, Castellà E, Grane N, Tural C, Rey-Joly C, Clotet B.

J Antimicrob Chemother. 2008 Jan;61(1):191-4. Epub 2007 Oct 31.

PMID:
17977910
[PubMed - indexed for MEDLINE]
Free Article
19.

Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.

Mildvan D, Creagh T, Leitz G; Anemia Prevalence Study Group.

Curr Med Res Opin. 2007 Feb;23(2):343-55.

PMID:
17288689
[PubMed - indexed for MEDLINE]
20.

Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency.

Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):27-35.

PMID:
17971714
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk